DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumorsAnbu Liu,Shaoting Zhang,Ming Wang,Liangying Zhang, Shidong Xu,Ahmad Nasimian,Shujing Li,Sien Zhao,Xu Cao,Jinhai Tian,Yuanyuan Yu,Zhaoyang Fan,Kun Xiao,Hui Zhao,Julhash U. Kazi,Lijun Ma,Jianmin SunMolecular Carcinogenesis（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
